nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0532	0.0532	CcSEcCtD
Gatifloxacin—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.0305	0.0305	CcSEcCtD
Gatifloxacin—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0273	0.0273	CcSEcCtD
Gatifloxacin—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0261	CcSEcCtD
Gatifloxacin—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0234	0.0234	CcSEcCtD
Gatifloxacin—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0218	0.0218	CcSEcCtD
Gatifloxacin—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0207	0.0207	CcSEcCtD
Gatifloxacin—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0204	0.0204	CcSEcCtD
Gatifloxacin—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.019	0.019	CcSEcCtD
Gatifloxacin—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0189	0.0189	CcSEcCtD
Gatifloxacin—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0187	CcSEcCtD
Gatifloxacin—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0185	CcSEcCtD
Gatifloxacin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0183	0.0183	CcSEcCtD
Gatifloxacin—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0182	CcSEcCtD
Gatifloxacin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.016	0.016	CcSEcCtD
Gatifloxacin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Gatifloxacin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0142	CcSEcCtD
Gatifloxacin—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0141	CcSEcCtD
Gatifloxacin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0131	CcSEcCtD
Gatifloxacin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0129	CcSEcCtD
Gatifloxacin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0124	CcSEcCtD
Gatifloxacin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0123	CcSEcCtD
Gatifloxacin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0122	CcSEcCtD
Gatifloxacin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0119	CcSEcCtD
Gatifloxacin—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Gatifloxacin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0114	CcSEcCtD
Gatifloxacin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Gatifloxacin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0112	CcSEcCtD
Gatifloxacin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Gatifloxacin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Gatifloxacin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0099	CcSEcCtD
Gatifloxacin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0097	0.0097	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00942	0.00942	CcSEcCtD
Gatifloxacin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00928	0.00928	CcSEcCtD
Gatifloxacin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0092	0.0092	CcSEcCtD
Gatifloxacin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0091	0.0091	CcSEcCtD
Gatifloxacin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00886	0.00886	CcSEcCtD
Gatifloxacin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00834	0.00834	CcSEcCtD
Gatifloxacin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00831	0.00831	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00831	0.00831	CcSEcCtD
Gatifloxacin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00814	0.00814	CcSEcCtD
Gatifloxacin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00814	0.00814	CcSEcCtD
Gatifloxacin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00799	0.00799	CcSEcCtD
Gatifloxacin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00762	0.00762	CcSEcCtD
Gatifloxacin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00762	0.00762	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00743	0.00743	CcSEcCtD
Gatifloxacin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00708	0.00708	CcSEcCtD
Gatifloxacin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00696	0.00696	CcSEcCtD
Gatifloxacin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00692	0.00692	CcSEcCtD
Gatifloxacin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00685	0.00685	CcSEcCtD
Gatifloxacin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00664	0.00664	CcSEcCtD
Gatifloxacin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00652	0.00652	CcSEcCtD
Gatifloxacin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00649	0.00649	CcSEcCtD
Gatifloxacin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00647	0.00647	CcSEcCtD
Gatifloxacin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00642	CcSEcCtD
Gatifloxacin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00616	CcSEcCtD
Gatifloxacin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00609	0.00609	CcSEcCtD
Gatifloxacin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00585	CcSEcCtD
Gatifloxacin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00559	CcSEcCtD
Gatifloxacin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00557	CcSEcCtD
Gatifloxacin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00556	CcSEcCtD
Gatifloxacin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00551	CcSEcCtD
Gatifloxacin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00549	CcSEcCtD
Gatifloxacin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00546	CcSEcCtD
Gatifloxacin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00532	CcSEcCtD
Gatifloxacin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00522	CcSEcCtD
Gatifloxacin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00519	CcSEcCtD
Gatifloxacin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0051	0.0051	CcSEcCtD
Gatifloxacin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00509	CcSEcCtD
Gatifloxacin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00502	CcSEcCtD
Gatifloxacin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00499	CcSEcCtD
Gatifloxacin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00492	CcSEcCtD
Gatifloxacin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0049	CcSEcCtD
Gatifloxacin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00483	CcSEcCtD
Gatifloxacin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00483	CcSEcCtD
Gatifloxacin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00483	CcSEcCtD
Gatifloxacin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00481	CcSEcCtD
Gatifloxacin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00467	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00463	CcSEcCtD
Gatifloxacin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00463	CcSEcCtD
Gatifloxacin—Infection—Riluzole—amyotrophic lateral sclerosis	0.0046	0.0046	CcSEcCtD
Gatifloxacin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00456	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00453	CcSEcCtD
Gatifloxacin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00452	0.00452	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00448	CcSEcCtD
Gatifloxacin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00441	CcSEcCtD
Gatifloxacin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00433	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00422	CcSEcCtD
Gatifloxacin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00419	CcSEcCtD
Gatifloxacin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00416	CcSEcCtD
Gatifloxacin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00413	CcSEcCtD
Gatifloxacin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00412	CcSEcCtD
Gatifloxacin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Gatifloxacin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00403	CcSEcCtD
Gatifloxacin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00396	CcSEcCtD
Gatifloxacin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00382	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00379	CcSEcCtD
Gatifloxacin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00368	CcSEcCtD
Gatifloxacin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00366	CcSEcCtD
Gatifloxacin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00366	CcSEcCtD
Gatifloxacin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00341	CcSEcCtD
Gatifloxacin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00332	CcSEcCtD
Gatifloxacin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00328	CcSEcCtD
Gatifloxacin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00317	CcSEcCtD
Gatifloxacin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00306	CcSEcCtD
Gatifloxacin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00294	CcSEcCtD
Gatifloxacin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00292	CcSEcCtD
Gatifloxacin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00292	CcSEcCtD
Gatifloxacin—Headache—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0029	CcSEcCtD
Gatifloxacin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00275	CcSEcCtD
